Bvf Inc

Bvf Inc reported 47 holdings worth US$3.04B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Bvf Inc reported 47 holdings worth US$3.04B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Kymera Therapeutics, Inc. and Xencor, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
47
Value as reported
US$3.04B

The filing in full

CompanySharesValue as reported% of portfolio
Revolution Medicines, Inc.2.46MUS$505M16.6%
Kymera Therapeutics, Inc.3.87MUS$433M14.2%
Xencor, Inc.6.23MUS$155M5.1%
Nektar Therapeutics2.13MUS$129M4.2%
Stoke Therapeutics, Inc.3.61MUS$93.8M3.1%
Tyra Biosciences, Inc.4.22MUS$92.2M3.0%
Zymeworks Inc.3.46MUS$91.8M3.0%
Cullinan Therapeutics, Inc.5.75MUS$88.3M2.9%
Structure Therapeutics, Inc.2.69MUS$84.2M2.8%
Palvella Therapeutics, Inc.607KUS$83.7M2.8%
Kura Oncology, Inc.6.69MUS$71.7M2.4%
Monte Rosa Therapeutics, Inc.4.28MUS$51M1.7%
Olema Pharmaceuticals, Inc.5.3MUS$45.8M1.5%
Crescent Biopharma, Inc.3.09MUS$45.1M1.5%
4D Molecular Therapeutics, Inc.2.88MUS$41.2M1.4%
Immunocore Holdings plc1.23MUS$37.3M1.2%
Annexon, Inc.8.28MUS$35M1.2%
Mirum Pharmaceuticals, Inc.407KUS$34.8M1.1%
Sagimet Biosciences Inc. - Series A3.5MUS$34.6M1.1%
Pyxis Oncology, Inc.11.8MUS$27.6M0.91%
Absci Corporation2.36MUS$25.4M0.84%
Invivyd, Inc.28.2MUS$24.5M0.81%
Anteris Technologies Global Corp.3MUS$23.3M0.77%
Foghorn Therapeutics Inc.5.84MUS$20.9M0.69%
Sutro Biopharma, Inc.1.25MUS$20.2M0.66%
Q32 Bio Inc.2.35MUS$19.4M0.64%
Alector, Inc.10MUS$18.6M0.61%
Eledon Pharmaceuticals, Inc.6.29MUS$15.9M0.52%
Disc Medicine, Inc.233KUS$15.3M0.50%
Avalo Therapeutics, Inc.907KUS$13.9M0.46%
OnKure Therapeutics, Inc.4.05MUS$11M0.36%
Immunic, Inc.765KUS$7.12M0.23%
TCGX Acquisition Corp.500KUS$6.25M0.21%
Research Alliance Corporation IV500KUS$5.92M0.19%
Research Alliance Corporation III500KUS$5.36M0.18%
Molecular Partners AG1.35MUS$5.19M0.17%
ImageneBio, Inc.1.11MUS$5.08M0.17%
X4 Pharmaceuticals, Inc.1.58MUS$4.57M0.15%
Inventiva SA686KUS$2.53M0.08%
TScan Therapeutics, Inc.5.56MUS$1.75M0.06%
Tenax Therapeutics, Inc.25,000US$47,250<0.01%
XOMA Royalty Corporation0US$00.00%

Source

Download original · View original at SEC

Related